Visitor Restrictions  |  COVID-19 Vaccine and Boosters  |  COVID-19 Testing

Menu
Close Search Opener

CTSU N1048: Phase 2/3 Trial of Neoadjuvant FOLFOX w. Selective Use of Combined Modality Chemotherapy v. Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection w. Total Mesorectal Excision

June 29, 2018
https://clinicaltrials.gov/ct2/show/NCT01515787
Cancer - Colorectal
Principal Investigator: unassigned
Cancer, Cancer Gastro, Rectal, Rectal Cancer, Advanced, Phase 2, Phase 3, Advanced Rectal Cancer, Low Anterior Resection, Total Mesorectal Excision, CTSU, FOLFOX
Open